STRC scaled to an aggregate stated amount of $3.4 billion, with a current dividend rate of 11.25% $413 million in cumulative distributions paid, representing a blended annual dividend rate of 9.6% ...
In 2025, my biotech-focused portfolio delivered a 34.3% average return, outperforming the S&P 500 by 20.6%. I prioritize small- and mid-cap biotechs with FDA-approved drugs entering commercialization, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results